Nalidixic acid resistance predicting reduced ciprofloxacin susceptibility of Salmonella enterica serovar Typhi

Asian Pacific Journal of Tropical Disease

Volumn 2, Issue SUPPL2, 2012, Pages

  Mandal, Shyamapada ^a   DebMandal, Manisha ^b   Pal, Nishith Kumar ^a  

^a CALCUTTA SCHOOL OF TROPICAL MEDICINE   (India)

^b MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

Ciprofloxacin resistance; Nalidixic acid surrogate marker; Salmonella enterica serovar Typhi

Indexed keywords

BIOLOGICAL MARKER; CIPROFLOXACIN; NALIDIXIC ACID;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM DETECTION; BACTERIUM ISOLATE; BLOOD SAMPLING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISK DIFFUSION; ESCHERICHIA COLI; HUMAN; HUMAN CELL; MICROBIOLOGICAL PARAMETERS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SALMONELLA TYPHI; SENSITIVITY AND SPECIFICITY; ZONE DIAMETER OF INHIBITION;

EID: 84871733465     PISSN: 22221808     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2222-1808(12)60226-6     Document Type: Article

References (16)

1. National Committee for Clinical Laboratory Standards: Performance Standards for antimicrobial disc susceptibility tests, 7th ed. Approved standards M2-A6 2000, National Committee for Clinical Laboratory Standards, Wayne Pa.
2. Kadhiravan T, Wig N, Kapil A, Kabra SK, Renuka K, Misra A Clinical outcomes in typhoid fever: adverse impact of infection with nalidixic acid-resistant Salmonella Typhi. BMC Infectious Diseases 2005, 5:37. 10.1186/1471-2334-5-37.
3. Renuka K, Sood S, Das BK, Kapil A High-level ciprofloxacin resistance in Salmonella enterica serotype Typhi in India. J Med Microbiol 2005, 54:999-1000.
4. Parry CM The treatment of multidrugresistant and nalidixic acid-resistant typhoid fever in Viet Nam. Trans R Soc Trop Med Hyg 2004, 98:413-422.
5. Rahman M, Siddique AK, Shoma S, Rashid H, Salam MA, Ahmed QS, et al. Emergence of multidrug-resistant Salmonella enterica serotype Typhi with decreased ciprofloxacin susceptibility in Bangladesh. Epidemiol Infect 2006, 134:433-438.
6. Asna SM, Haq JA, Rahman M Nalidixic acid-resistant Salmonella enterica serovar Typhi with decreased susceptibility to ciprofloxacin caused treatment failure: a report from Bangladesh. Jpn J Infect Dis 2003, 56:32-33.
7. Kapil AR, Das B Nalidixic acid susceptibility test to screen ciprofloxacin resistance in Salmonella Typhi. Ind J Med Res 2002, 115:49-54.
8. Ray P, Sharma J, Marak RSK, Garg RK Predictive efficacy of nalidixic acid resistance as a marker of fluoroquinolone resistance in Salmonella enterica var Typhi. Indian J Med Res 2006, 124:105-108.
9. Mandal S. Antibiotic resistance of Salmonella Typhi in Kolkata (1991-2001) and in vitro experiments on effect of combined chemotherapy. Thesis: Jadavpur University, Kolkata, India. 2005; 1-191.
10. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility testings. Fifteenth Informational Supplement. CLSI document M100-S15. Clinical and Laboratory Standards Institute, 2005, Wayne, PA.
11. Gopalakrishnan V, Sekhar WY, Soo EH, Vinsent RA, Devi S Typhoid fever in Kuala Lumpur and a comparative evaluation of two commercial diagnostic kits for the detection of antibodies to Salmonella Typhi. Singapore Med J 2002, 43:354-358.
12. Crump JA, Barrett TJ, Nelson JT, Angulo FJ Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae. Clin Infect Dis 2003, 37:75-81.
13. Capoor MR, Nair D, Aggarwal P, Mathys V, Dehem M, Bifani PJ Salmonella enterica Serovar Typhi: Molecular Analysis of Strains with Decreased Susceptibility and Resistant to Ciprofloxacin in India from 2001-2003. Brazilian J Infect Dis 2007, 11:423-425.
14. Lynch MF, Blanton EM, Bulens S, Polyak C, Vojdani J, Medalla F Typhoid Fever in the United States, 1999-2006. JAMA 2009, 302(8):859-865.
15. Threlfall EJ, Skinner JA, Ward LR Detection of decreased in vitro susceptibility to ciprofloxacin in Salmonella enterica serotypes Typhi and paratyphi A. J Antimicrob Chemother 2001, 48:740-741.
16. Dimitrov T, Udo EE, Albaksami O, Kilani AA, Shehab EMR Ciprofloxacin treatment failure in a case of typhoid fever caused by Salmonella enterica serotype Paratyphi A with reduced susceptibility to ciprofloxacin. J Med Microbiol 2007, 56:277-279.